India's Zydus Cadila COVID-19 vaccine receives emergency use authorization
By Trend
Indian drugmaker Zydus Cadila on Friday received emergency use authorization from the country's drug regulator -- Drugs Controller General of India (DCGI) for its three-dose COVID-19 vaccine ZyCov-D, officials said, Trend reports citing Xinhua.
"Zydus Cadila has received approval for emergency use authorization from the DCGI for ZyCoV-D today, the world's first and India's indigenously developed DNA based vaccine for COVID-19 to be administered in humans including children and adults 12 years and above," a statement issued by the federal ministry of science and technology said.
ZyCov-D is developed in partnership with the department of biotechnology and implemented by the Biotechnology Industry Research Assistance Council.
---
Here we are to serve you with news right now. It does not cost much, but worth your attention.
Choose to support open, independent, quality journalism and subscribe on a monthly basis.
By subscribing to our online newspaper, you can have full digital access to all news, analysis, and much more.
You can also follow AzerNEWS on Twitter @AzerNewsAz or Facebook @AzerNewsNewspaper
Thank you!